ELMS STEVE (CIK 1250195) reported 17 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-09). Recent activity: Buy ADMA (7,000 shares), Buy ADMA (7,000 shares), Buy ADMA (10,690 shares), Sell ADMA (92,941 shares), Buy ADMA (9,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-09 | ADMA BIOLOGICS, INC. (ADMA) | Director | Buy | 7,000 | $109,690 |
| 2026-03-09 | ADMA BIOLOGICS, INC. (ADMA) | Director | Buy | 7,000 | $107,730 |
| 2026-02-11 | ADMA BIOLOGICS, INC. (ADMA) | Director | Buy | 10,690 | $0 |
| 2025-06-16 | ADMA BIOLOGICS, INC. (ADMA) | Director | Sell | 92,941 | $2.0M |
| 2025-06-16 | ADMA BIOLOGICS, INC. (ADMA) | Director | Buy | 9,000 | $53,640 |
| 2025-06-16 | ADMA BIOLOGICS, INC. (ADMA) | Director | Buy | 10,000 | $50,000 |
| 2025-06-16 | ADMA BIOLOGICS, INC. (ADMA) | Director | Buy | 53,837 | $197,043 |
| 2025-06-16 | ADMA BIOLOGICS, INC. (ADMA) | Director | Buy | 17,500 | $85,925 |
| 2025-06-16 | ADMA BIOLOGICS, INC. (ADMA) | Director | Buy | 30,000 | $116,700 |
| 2025-06-16 | ADMA BIOLOGICS, INC. (ADMA) | Director | Buy | 15,000 | $43,800 |
| 2025-06-16 | ADMA BIOLOGICS, INC. (ADMA) | Director | Buy | 55,000 | $129,250 |
| 2025-06-16 | ADMA BIOLOGICS, INC. (ADMA) | Director | Buy | 53,172 | $88,797 |
| 2025-06-16 | ADMA BIOLOGICS, INC. (ADMA) | Director | Buy | 51,630 | $172,960 |
| 2025-06-16 | ADMA BIOLOGICS, INC. (ADMA) | Director | Buy | 37,541 | $202,721 |
| 2025-06-16 | ADMA BIOLOGICS, INC. (ADMA) | Director | Sell | 137,931 | $2.9M |
| 2025-06-16 | ADMA BIOLOGICS, INC. (ADMA) | Director | Sell | 194,749 | $3.9M |
| 2025-02-21 | ADMA BIOLOGICS, INC. (ADMA) | Director | Buy | 10,889 | $0 |
Source: SEC Form 4 filings · as of 2026-03-09